Skip to main content

VIEW OUR UPCOMING VIRTUAL & IN-PERSON EVENTS

small background image large background image

You Can Outsource the Work. Not the Oversight.

Small and mid-size biotechs rely on CROs and vendors to run their trials. But the sponsor stays accountable for the Trial Master File (TMF), and ICH E6(R3) makes that expectation clearer than ever. See how four biotechs took ownership of their TMF with Trial Interactive.

Results at a glance

~2 million legacy documents

Migrated in 3-6 months

From the first trial

A sponsor-owned eTMF and eISF in place before going multi-site

Zero full-time headcount

Added to achieve full TMF oversight

ICH E6(R3) Puts Sponsor Oversight Front and Center

ICH finalized the revised Good Clinical Practice (GCP) guideline in January 2025. It took effect in the EU on July 23, 2025, and the FDA published it in September 2025. Three themes stand out for sponsors who outsource:
• Delegating doesn’t transfer responsibility. Sponsors can delegate tasks to CROs and other service providers, but they remain accountable for how those tasks are carried out.
• Oversight should be risk-based and documented. E6(R3) expects oversight that reflects the trial’s risk and complexity, along with evidence that it actually occurred.
• “Service providers,” not just CROs. The guideline’s wording reflects the growing number of specialist vendors sponsors use. All fall under the sponsor’s oversight.
Your TMF is where that oversight is recorded. If it lives only in a CRO’s system, it’s harder to see, harder to control, and harder to defend at inspection.

What Sponsor-Owned Really Looks Like

• The sponsor holds the record. Each company moved its TMF out of CRO-only systems or scattered folders and into an environment it controls, with direct access to documents, metadata, and audit trails.
• Ownership doesn’t need a big team. Document processing, QC, TMF study owners, and FSP support let lean ClinOps teams keep control without building a large in-house function.
• Structure comes before scale. Ethris and EnteroBiotix built their foundations early. Akebia and iOnctura consolidated what they already had. Both routes end in a TMF that can grow with the pipeline.
• Oversight you can measure. SSU completeness reviews, KPI dashboards, and end-of-study quality reviews turn oversight from an intention into evidence.
• Inspection readiness is the proof. Whether through a full mock inspection or quality-reviewed legacy archives, the goal is a TMF that can withstand scrutiny.

Technology and TMF Expertise from One Partner

Trial Interactive, part of TransPerfect, combines a connected eClinical platform with expert TMF services, so sponsors can choose how much support they need, from software alone to a full FSP model.

  • eTMF: A sponsor-owned TMF with real-time visibility into completeness and quality

  • Study Start-Up and CTMS: Structured oversight of CRO and vendor performance from day one

  • eISF: Site files connected to the eTMF

  • LMS and QDMS: Training and quality records managed digitally and filed to the TMF

  • Archiving: Secure, compliant long-term storage for legacy and completed studies

  • TMF Services: Document QC, TMF study owners, consulting, workshops, migration, and flexible FSP support

See how Akebia, Ethris, EnteroBiotix, and iOnctura took ownership of their TMF and strengthened oversight of CROs with Trial Interactive’s eTMF and TMF Services.